View of Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic

Return to Article Details Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic Download Download PDF